| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
26,107 |
23,460 |
$3.87M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
20,765 |
17,959 |
$3.37M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,123 |
26,671 |
$2.87M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,794 |
2,451 |
$618K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,157 |
14,588 |
$587K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,019 |
3,464 |
$464K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,594 |
8,276 |
$434K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,668 |
4,984 |
$345K |
| 71045 |
Radiologic examination, chest; single view |
13,411 |
11,818 |
$280K |
| 80053 |
Comprehensive metabolic panel |
28,239 |
24,536 |
$206K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,770 |
24,051 |
$149K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,719 |
2,532 |
$126K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,820 |
3,503 |
$109K |
| 83880 |
|
4,446 |
3,867 |
$108K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,188 |
2,062 |
$105K |
| 84484 |
|
11,897 |
7,720 |
$103K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,142 |
1,969 |
$97K |
| 99460 |
|
2,142 |
2,028 |
$88K |
| 80050 |
General health panel |
2,182 |
1,893 |
$82K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,170 |
1,032 |
$80K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,971 |
2,789 |
$78K |
| 36415 |
Collection of venous blood by venipuncture |
35,563 |
29,603 |
$70K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,667 |
3,435 |
$51K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
355 |
320 |
$50K |
| 74022 |
|
1,083 |
985 |
$47K |
| 81025 |
|
7,273 |
6,529 |
$47K |
| G0378 |
Hospital observation service, per hour |
866 |
403 |
$46K |
| 71046 |
Radiologic examination, chest; 2 views |
1,146 |
1,005 |
$44K |
| 83690 |
|
7,903 |
7,015 |
$40K |
| 58558 |
|
211 |
160 |
$37K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,813 |
4,834 |
$35K |
| 81001 |
|
16,179 |
13,741 |
$34K |
| 74018 |
|
1,143 |
1,017 |
$33K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,151 |
1,010 |
$33K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,477 |
4,802 |
$32K |
| 87400 |
|
2,613 |
2,014 |
$31K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
524 |
453 |
$29K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,768 |
2,409 |
$28K |
| 85730 |
|
6,242 |
5,390 |
$23K |
| 85610 |
|
8,178 |
7,162 |
$23K |
| 49320 |
|
105 |
80 |
$22K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
66 |
51 |
$20K |
| 00840 |
|
178 |
157 |
$20K |
| 80143 |
|
1,748 |
1,507 |
$19K |
| 87081 |
|
2,980 |
2,805 |
$18K |
| 80179 |
|
1,662 |
1,430 |
$18K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
499 |
473 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,560 |
4,091 |
$16K |
| 87088 |
|
2,432 |
2,176 |
$15K |
| 85379 |
|
2,156 |
1,900 |
$15K |
| 82550 |
|
3,279 |
2,910 |
$14K |
| 87040 |
|
1,805 |
1,177 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,880 |
8,706 |
$14K |
| 82150 |
|
2,675 |
2,406 |
$13K |
| 82077 |
|
1,164 |
999 |
$12K |
| 84703 |
|
1,758 |
1,589 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
173 |
149 |
$10K |
| 81003 |
|
6,752 |
5,692 |
$10K |
| 99462 |
|
454 |
373 |
$10K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,004 |
3,014 |
$9K |
| 73562 |
|
112 |
92 |
$8K |
| 83605 |
|
823 |
701 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
812 |
729 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
493 |
444 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,307 |
4,554 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
42 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
206 |
190 |
$5K |
| 82553 |
|
657 |
591 |
$5K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
26 |
26 |
$4K |
| 73130 |
|
52 |
49 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,568 |
6,929 |
$4K |
| 80320 |
|
2,900 |
1,760 |
$4K |
| 85027 |
|
800 |
703 |
$3K |
| 00811 |
|
38 |
38 |
$3K |
| 80061 |
Lipid panel |
262 |
247 |
$3K |
| 83735 |
|
637 |
549 |
$3K |
| 70486 |
|
12 |
12 |
$3K |
| 87186 |
|
384 |
354 |
$2K |
| 73630 |
|
27 |
26 |
$2K |
| 84439 |
|
359 |
296 |
$2K |
| 87077 |
|
323 |
301 |
$2K |
| 00731 |
|
44 |
40 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
127 |
29 |
$2K |
| 87420 |
|
126 |
119 |
$2K |
| 76536 |
|
27 |
24 |
$2K |
| 82607 |
|
125 |
113 |
$1K |
| 00120 |
|
12 |
12 |
$1K |
| 80329 |
|
234 |
133 |
$1K |
| 70220 |
|
32 |
28 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
17 |
15 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
124 |
119 |
$1K |
| 87807 |
|
100 |
93 |
$1K |
| 82746 |
|
99 |
89 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
525 |
412 |
$994.55 |
| 84702 |
|
138 |
121 |
$978.25 |
| 73610 |
|
13 |
12 |
$974.51 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,340 |
966 |
$963.20 |
| 85007 |
|
459 |
409 |
$931.67 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
61 |
51 |
$902.67 |
| 90715 |
|
71 |
65 |
$846.35 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
34 |
33 |
$800.00 |
| 83525 |
|
68 |
66 |
$754.38 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
89 |
80 |
$687.80 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
478 |
453 |
$590.70 |
| 59025 |
Fetal non-stress test |
27 |
12 |
$552.72 |
| 85652 |
|
257 |
242 |
$532.66 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,207 |
863 |
$510.34 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
493 |
395 |
$468.11 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,137 |
888 |
$391.99 |
| 31000 |
|
16 |
12 |
$302.44 |
| J2704 |
Injection, propofol, 10 mg |
2,273 |
1,576 |
$267.24 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
21 |
13 |
$93.66 |
| J1644 |
Injection, heparin sodium, per 1000 units |
21 |
14 |
$74.62 |
| 86140 |
|
15 |
15 |
$69.23 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
427 |
301 |
$59.58 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,658 |
1,198 |
$57.72 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,526 |
1,233 |
$50.89 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
201 |
127 |
$50.74 |
| 99152 |
|
19 |
13 |
$37.17 |
| 86901 |
|
76 |
67 |
$32.89 |
| 86900 |
|
76 |
67 |
$32.89 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
43 |
40 |
$14.24 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
941 |
578 |
$5.36 |
| A9270 |
Non-covered item or service |
761 |
457 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
179 |
130 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
15 |
12 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
91 |
51 |
$0.00 |
| 00000 |
|
303 |
269 |
$0.00 |
| C1769 |
Guide wire |
99 |
65 |
$0.00 |
| 88304 |
|
25 |
25 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
139 |
25 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
40 |
39 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
130 |
26 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
45 |
25 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
63 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
15 |
14 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,774 |
162 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
70 |
42 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
15 |
12 |
$0.00 |
| L8613 |
Ossicula implant |
13 |
12 |
$0.00 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
24 |
16 |
$0.00 |